rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Adenoid cystic carcinoma of the salivary glands
    sub title: a pilot study of potential therapeutic targets and characterization of the immunological tumor environment and angiogenesis
  name:
    name part: Michaelides, Ioannis
    name part: 1990-
    role:
      role term: creator
    role:
      role term: VerfasserIn
    role:
      role term: aut
  name:
    name part: Künzel, Julian
    name part: 1983-
    role:
      role term: VerfasserIn
    role:
      role term: aut
  name:
    name part: Ettl, Tobias
    name part: 1977-
    role:
      role term: VerfasserIn
    role:
      role term: aut
  name:
    name part: Beckhove, Philipp
    name part: 1969-
    role:
      role term: VerfasserIn
    role:
      role term: aut
  name:
    name part: Bohr, Christopher
    name part: 1974-
    role:
      role term: VerfasserIn
    role:
      role term: aut
  name:
    name part: Brochhausen, Christoph
    name part: 1969-
    role:
      role term: VerfasserIn
    role:
      role term: aut
  name:
    name part: Mamilos, Andreas
    name part: 1986-
    role:
      role term: VerfasserIn
    role:
      role term: aut
  type of resource: text
  origin info:
    place:
      place term: xx
    date issued: 2023
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: remote
    extent: Illustrationen
    extent: 8
  abstract: Adenoid cystic carcinoma (ACC) is a rare type of cancer commonly occurring in salivary glands. It is characterized by slow but infiltrative growth, nerve infiltration and overall poor prognosis, with late recurrence and distant metastasis. The treatment of ACC is still limited to surgery and/or (adjuvant) radiotherapy. Till now no promising systemic therapy option exists. However, various studies deliver promising results after treatment with anti-angiogenetic agents, such as anti-EGFR-antibody Cetuximab or Tyrosinkinase inhibitor Lenvatinib.
  note: Ioannis Michaelides, Julian Künzel, Tobias Ettl, Philipp Beckhove, Christopher Bohr, Christoph Brochhausen, Andreas Mamilos
  note: Online veröffentlicht: 1. März 2023
  note: Gesehen am 21.08.2024
  subject:
    topic: Adenoid cystic carcinoma
  subject:
    topic: Macrophage polarization
  subject:
    topic: Neovascularization
  subject:
    topic: Salivary gland cancer
  classification: 33
  related item:
    title info:
      title: European archives of oto-rhino-laryngology and head & neck
    name:
      name part: Adenoid cystic carcinoma of the salivary glands a pilot study of potential therapeutic targets and characterization of the immunological tumor environment and angiogenesis
    origin info:
      publisher: Berlin : Springer, 1864
    physical description:
      extent: Online-Ressource
    identifier: 1434-4726
    identifier: (DE-627)253722667
    identifier: (DE-600)1459042-6
    identifier: (DE-576)072372532
    part:
      text: 280(2023), 6, Seite 2937-2944
  related item:
    name:
      name part: Adenoid cystic carcinoma of the salivary glands a pilot study of potential therapeutic targets and characterization of the immunological tumor environment and angiogenesis
    part:
      text: volume:280
    part:
      text: year:2023
    part:
      text: number:6
    part:
      text: pages:2937-2944
    part:
      text: extent:8
  identifier: https://doi.org/10.1007/s00405-023-07884-3
  identifier: https://link.springer.com/article/10.1007/s00405-023-07884-3
  record info:
    record content source: DE-627
    record creation date: 240821
    record change date: 20241205164129.0
    record identifier: 1899268596
    language of cataloging:
      language term: ger